BLU-5937(一种选择性P2X3拮抗剂)在基线清醒咳嗽频率定义的患者亚组中24小时咳嗽频率的改善

{"title":"BLU-5937(一种选择性P2X3拮抗剂)在基线清醒咳嗽频率定义的患者亚组中24小时咳嗽频率的改善","authors":"J. Smith, A. Morice, S. Birring, S. Parker, P. Marsden, J. Holcomb, B. Prenner, M. Sher, G. Steven, L. Mcgarvey, D. Garceau, C. Bonuccelli, L. Harvey","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1019","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":403254,"journal":{"name":"A6. A006 HOT TAKES FROM CLINICAL TRIALS IN LUNG DISEASE","volume":"223 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Improvements in Cough Frequency Over 24 Hours with BLU-5937, a Selective P2X3 Antagonist, in Patient Subgroups Defined by Baseline Awake Cough Frequencies\",\"authors\":\"J. Smith, A. Morice, S. Birring, S. Parker, P. Marsden, J. Holcomb, B. Prenner, M. Sher, G. Steven, L. Mcgarvey, D. Garceau, C. Bonuccelli, L. Harvey\",\"doi\":\"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":403254,\"journal\":{\"name\":\"A6. A006 HOT TAKES FROM CLINICAL TRIALS IN LUNG DISEASE\",\"volume\":\"223 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A6. A006 HOT TAKES FROM CLINICAL TRIALS IN LUNG DISEASE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A6. A006 HOT TAKES FROM CLINICAL TRIALS IN LUNG DISEASE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}